Language selection

Search

Patent 2267929 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent Application: (11) CA 2267929
(54) English Title: PREPARATION OF SATURATED PHYTOSTEROLS
(54) French Title: PREPARATION DE PHYTOSTEROLS SATURES
Status: Deemed Abandoned and Beyond the Period of Reinstatement - Pending Response to Notice of Disregarded Communication
Bibliographic Data
(51) International Patent Classification (IPC):
  • C07J 9/00 (2006.01)
  • C11B 13/00 (2006.01)
(72) Inventors :
  • WONG, ALFRED (Canada)
  • BOGUSKI, WILFRED NICHOLAS (Canada)
(73) Owners :
  • FORBES MEDI-TECH INC.
(71) Applicants :
  • B.C. CHEMICALS LTD. (Canada)
(74) Agent: SUSAN M. BEN-OLIELBEN-OLIEL, SUSAN M.
(74) Associate agent:
(45) Issued:
(22) Filed Date: 1999-04-06
(41) Open to Public Inspection: 2000-10-06
Availability of licence: N/A
Dedicated to the Public: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): No

(30) Application Priority Data: None

Abstracts

English Abstract


An end product mixture substantially comprising saturated phytosterols is
prepared
from a raw material mixture of phytosterols derived from tall oil. At least a
substantial
portion of the raw material mixture consists of unsaturated phytosterols. The
method
includes the step of hydrogenating the raw material mixture in a solvent
substantially
comprising ethyl acetate while in the presence of a hydrogenation catalyst,
then filtering and
drying the hydrogenation product to separate the mixture of saturated
phytosterols from the
solvent and to leave an amount of solvent residue in the mixture that is not
greater than a
desired amount. Hydrogenation is carried out at a temperature greater than 35
deg. C.,
preferably 40 deg. C or higher, and at a pressure greater than standard
pressure, preferably 20
psi or higher. The resulting mixture of saturated phytosterols may be used for
various
purposes including the manufacture of food additives or dietary supplements
with a view to
facilitating the reduction of serum cholesterol levels.


Claims

Note: Claims are shown in the official language in which they were submitted.


WE CLAIM:
1. A method for the preparation of an end product mixture of phytosterols, at
least a
substantial portion of said mixture consisting of saturated phytosterols, from
a raw material
mixture of phytosterols derived from tall oil, at least a substantial portion
of said raw material
mixture consisting of unsaturated phytosterols, said method comprising the
steps of:
a method for the preparation of an end product mixture of phytosterols, at
least a substantial
portion of which mixture consists of saturated phytosterols, from a raw
material
(a) hydrogenating said raw material mixture in a solvent substantially
comprising
ethyl acetate while in the presence of a hydrogenation catalyst to produce a
hydrogenation product comprising said end product mixture in said solvent,
said
hydrogenating step being carried out at a temperature greater than 35 deg. C.
and
a pressure greater than standard pressure; and,
(b) filtering and drying said hydrogenation product to separate said end
product
mixture from said solvent and to thereby leave an amount of solvent residue in
said end product mixture that is not greater than a desired amount.
2. A method as defined in claim 1, wherein said hydrogenating step is carried
out at
temperature of about 40 deg. C.
3. A method. as defined in claim 1, wherein said hydrogenating step is carried
out at a
temperature of at least 40 deg. C.
4. A method as defined in claim 1, wherein said hydrogenating step is carried
out at a
temperature of about 100 deg. C.
5. A method as defined in claim 1, wherein said hydrogenating step is carried
out at a
temperature of at least 100 deg. C.
6. A method as defined in any one or more of claims 1 to 5, wherein said
hydrogenating
step is carried out at a pressure of about 20 psi.
-9-

7. A method as defined in any one or more of claims 1 to 5, wherein said
hydrogenating
step is carried out at a pressure of at least 20 psi.
8. A method as defined in any one or more of claims 1 to 5, wherein a
substantial
portion of said raw material mixture is .beta.-sitosterol.
9. A method as defined in any one or more of claims 1 to 5, wherein a
substantial
portion of said raw material mixture is .beta.-sitosterol, and wherein said
hydrogenating step is
carried out at a pressure of about 20 psi.
10. A method as defined in any one or more of claims 1 to 5, wherein a
substantial
portion of said raw material mixture is .beta.-sitosterol, and wherein said
hydrogenating step is
carried out at a pressure of at least 20 psi.
11. A method as defined in any one or more of claims 1 to 10 wherein said
hydrogenation
catalyst is palladium.
-10-

Description

Note: Descriptions are shown in the official language in which they were submitted.


CA 02267929 1999-04-06
PREPARATION OF SATURATED PHYTOSTEROLS
FIELD OF THE INVENTION
The present invention relates to the preparation of saturated phytosterols
and, more
particularly, to a method of preparing an end product mixture of saturated
phytosterols, at
s least a substantial of the mixture consisting of saturated phytosterols,
from a raw material
mixture of phytosterols derived from tall oil, at least a substantial portion
of the raw material
mixture consisting of unsaturated phytosterols.
BACKGROUND TO THE INVENTION
It has been known for many years that plant sterols or phytosterols can serve
to
to effectively reduce serum cholesterol levels. In various studies, (3--
sitosterol and, even
moreso, its hydrogenated form (13-sitostanol), has been recognized as
particularly efficacious.
One important source of phytosterols is tall oil, and there are known methods
for
isolating phytosterols and their saturated or hydrogenated (stanol) forms
either from tall oil
soap (sometimes referred to as soap skimmings) or from tall oil pitch.
15 When phytosterols are isolated from tall oil, a portion of the isolated mix
(normally
including l~sitosterol and campesterol) will typically include at least some
hydrogenated
forms of the sterols (viz. f3-sitostanol and campestanol). However, given the
higher efficacy
of 13--sitostanol compared to 13-sitosterol, it is desirable that
substantially all 13-sitosterols
present in any such mix should be converted to f~sitostanols.
2o The conversion of a sterol to a stanol is, by definition, hydrogenation.
Generally, it is
known to hydrogenate a phytosterol or a phytosterol mixture by mixing the
phytosterol with
a solvent in a reactor in the presence of an appropriate catalyst. However,
while
hydrogenation is mandated, relatively little attention has been paid to how
hydrogenation
-1-

CA 02267929 1999-04-06
may best be achieved, including which solvent may be best suited to the
hydrogenation
process.
From an economic or commercial point of view, it is highly desirable to effect
the
hydrogenation of a phytosterol or a phytosterol mix as quickly as possible. In
this regard, it
is recognized that one possible way to accelerate the hydrogenation process is
to carry out the
process at an elevated temperature or at an elevated temperature and pressure.
However, if
the temperature is excessive, then the phytosterols will degrade or break
down.
Further, and again from an economic or commercial point of view, it is highly
desirable to be able to produce high purity saturated phytosterols while
recycling or reusing
1o the hydrogenation solvent with many successive batches of raw material
phytosterols.
However, the ability to do so can be impaired if the execution of the
hydrogenation process
introduces impurities or contaminants either as the result of phytosterol
break down or
otherwise. Impurities or contaminants that are carried with the saturated
phytosterols may, at
added cost, require removal. Likewise, to extend the lifetime of the
hydrogenation solvent,
~ 5 any impurities or contaminants that are carried with the solvent may
require removal before
the solvent is recycled.
A further important factor that contributes to the overall cost of producing
saturated
phytosterols is the time that it takes to dry or sufficiently remove the
presence of solvent
from the end product. When saturated phytosterols are to be used in the
preparation of food
20 additives or dietary supplements, government regulations typically will
permit the presence
of only a very small amount of solvent residue (for example, SO parts per
million).
Accordingly, a primary object of the present invention is to provide a new and
improved method for efficiently preparing a high purity end product mixture of
saturated
phytosterols from a raw mixture of phytosterols derived from tall oil - and
one which
25 converts a high percentage of unsaturated phytosterols present in the raw
material mixture to
corresponding saturated phytosterols.
-2-

CA 02267929 1999-04-06
SUMMARY OF THE INVENTION
In accordance with a broad aspect of the present invention, there is provided
a method
for the preparation of an end product mixture of phytosterols, at least a
substantial portion of
the mixture consisting of saturated phytosterols, from a raw material mixture
of phytosterols
derived from tall oil, at least a substantial portion of the raw material
mixture consisting of
unsaturated phytosterols, such method comprising the steps of
(a) hydrogenating the raw material mixture in a solvent substantially
comprising ethyl
acetate while in the presence of a hydrogenation catalyst to produce a
hydrogenation
product comprising the end product mixture in the solvent; and,
to (b) filtering and drying the hydrogenation product to separate the end
product mixture
from the solvent and to thereby leave an amount of solvent residue in the end
product
mixture that is not greater than a predetermined amount.
During hydrogenation, the temperature is greater than 35 deg. C. (preferably
about 40
deg. C. or higher) and the pressure is greater than standard pressure
(preferably about 20 psi
15 or higher). Suitable catalysts include platinum dioxide and palladium.
However, by reason
of its lower cost, the latter is preferred.
After filtering and drying to reduce the amount of solvent and solvent
residue, the
resulting end product mixture of saturated phytosterols may be used for
various purposes
including the manufacture of food additives or dietary supplements with a view
to facilitating
?o the reduction of serum cholesterol levels.
Herein, and in the claims, it is to be understood that pressures when
expressed as
"psi" are pressures relative to standard pressure. Thus, for example, 20 psi
as used above
means 20 psi in excess of standard pressure. Standard pressure is about 14.7
pounds per
square inch absolute.
_3_

CA 02267929 1999-04-06
Solvents other than ethyl acetate may be used to prepare a mixture of
saturated
phytosterols from a mixture of unsaturated phytosterols derived from tall oil.
Such other
solvents include ethanol and isopropanol. However, ethyl acetate has been
found to produce
surprisingly unique results. With ethyl acetate, it is possible not only to
achieve conversion
ratios above 97% and approaching 99% or higher but, in so doing, to produce a
resulring
saturated phytosterol mixture that has particularly high purity. Moreover, it
has been found
that a saturated phytosterol mixture produced with ethyl acetate as the
solvent can be filtered
and dried (e.g. to less than 50 ppm solvent residue) substantially more
efficiently than when
produced with solvents such as ethanol or isopropanol.
to BRIEF DESCRIPTION OF THE DRAWINGS
The FIGURE is a representation of a gas chromatograph (GC) trace obtained upon
hydrogenation of a raw material mixture of phytosterols as described below, in
part serving
to illustrate results that are achieved when (in accordance with the present
invention) ethyl
acetate is used as the hydrogenation solvent, and also serving to illustrate
results that are
15 achieved when (not in accordance with the present invention) ethanol or
ispropanol is used as
the hydrogenation solvent.
DETAILED DESCRIPTION
As noted above, raw material phytosterol mixtures that are isolated from tall
oil
typically will include both unsaturated and saturated phytosterols. In more
detail, Table 1
?o below indicates characteristics of raw material crystalline mixes that may
be derived from
softwood trees indigenous to northern British Columbia (including spruce,
lodgepole pine
and sub-alpine fir).
-4-

CA 02267929 1999-04-06
TA BLE 1.
T_y ip cal Values
Phytosterols: > 95% by weight
(3--sitosterol 55 - 60% by weight
l~sitostanol 12 - 18% by weight
campesterol 12 - 17% by weight
campestanol 2 - 4% by weight
other sterols < 3% by weight
Melting Point 132 - 140 deg. C.
to Phytosterol mixtures as indicated in Table 1 may be used in the manufacture
of
cholesterol lowering agents without any hydrogenation step. However,
hydrogenation is
desirable because 13-sitostanol is recognized as having an efficacy
significantly higher and an
absorption rate significantly lower than f3-sitosterol.
Raw material mixtures as indicated in Table 1 are themselves considered useful
to be
used directly for the manufacture of food additives or dietary supplements
that have serum
cholesterol lowering properties. However, hydrogenation is desirable because
13--sitostanol is
recognized as having particularly high efficacy and because f3-sitosterol is
the most plentiful
unhydrogenated phytosterol.
Several tests were conducted under various conditions of temperature and
pressure
2o utilizing raw material (RM) mixes like that indicated in Table 1. In each
case, the raw
material mixture was first mixed with ethyl acetate (ETAC), then introduced
together with a
hydrogenation catalyst (CAT) to a stirred reactor where hydrogenation took
place under
controlled conditions of temperature and pressure. The catalyst used was 5%
palladium on a
carbon support. Thereafter, the hydrogenation product (viz. the end product
mixture of
-5-

CA 02267929 1999-04-06
phytosterols
in
the
solvent)
was
filtered,
cooled,
separated
and
dried
by
conventional
means
well nown to thoseled in
k skil the art.
GC analysis then usedanalyze the ure and
was to end product to calculate
mixt the
percen tage of stanols Table 2 summarizes conditions
present the and results.
therein. test
TABLE 2
Test RM/SOL CAT/RM H2 press. Temp. Run Time Conversion
(wt %) (wt %) (psi) (C) (min.) (%)
2.01 8 10 20 20 1.20 50
2.02 8 10 20 30 I20 73
2.03 8 10 20 40 120 98
2.04 8 10 20 50 120 99
2.05 8 10 40 SO 120 99
2W 8 10 40 65 120 99
2.07 8 10 65 65 120 99
2.08 8 6 75 100 120 97
2.09 8 6 75 100 120 97
2.10 8 6 75 100 120 98
2.11 8 9 75 100 120 97
2.12 8 10 7S 100 120 99
2.13 15 10 75 100 120 99
2.14 15 10 75 100 240 100
2.15 8 10 75 100 120 98
In Table 2, the column headed "Conversion" is a calculation of 100% times the
amount of saturated phytosterols present in the end product mixture divided by
the sum of
such amount and the amount of unsaturated phytosterols present in the end
product mixtures.
The amounts were determined in mg/g from the analysis of the GC traces.
1o From Table 2, it will be noted that there is a rapid decrease in percent
conversion as
the temperature of hydrogenation drops below 40 deg. C. For this reason, the
temperature
-6-

CA 02267929 1999-04-06
used in accordance with the invention is greater than 35 deg. C, and
preferably about 40 deg.
C. or higher where the percent conversion is in the high 90% range.
Further, although a relatively high percent conversion is shown at 40 deg. C
and a
hydrogen pressure of 20 psi, it is noteworthy that the percent conversion
remains high at
elevated temperatures and pressures. This indicates a substantial absence of
phytosterol
break down under such elevated conditions. Further, since conversion
efficiency is
approximately the same at 75 psi and 100 deg. C as it is at 20 psi and 40 deg.
C, and since the
conversions taking place may be accelerated at higher temperatures and
pressures, it follows
that comparable results should be achieved with run times less than 120
minutes as used in
i o most of the tests.
Apart from the high conversion efficiencies that can be achieved while using
ethyl
acetate as the hydrogenation solvent, it has also been found that required
drying times are
significantly less than is required with other solvents such as ethanol and
isopropanol. By
way of example, a sample of raw material like that shown in Table 1 that was
hydrogenated
in ethyl acetate in the manner described above was dried for 2 hours at 105
deg. C under an
absolute pressure of 25 mmhg. The result was fine white phytosterol crystals
containing less
than 50 ppm ethyl acetate. In comparison, the amount of solvent residue
remaining in like
samples that were hydrogenated in ethanol and in isopropanol exceeded ten
times this
amount after drying for twice as long.
2o Reduced drying time represents a significant advantage that ethyl acetate
provides
over solvents such as ethanol and isopropanol. However, it has also been found
the use of
ethyl acetate mitigates against impurities that tend to appear in the end
product mixture when
ethanol or isopropanol is used.
More particularly, reference is now made to the FIGURE. Except as noted below,
the
FIGURE is generally representative of GC traces that will be obtained upon
hydrogenation of
a raw material mixture like that indicated in Table 1. As shown, the trace
includes three
major peaks:

CA 02267929 1999-04-06
Peak 1 Internal Standard (cholesterol)
Peak 2 Campestanol
Peak 3 13-sitostanol
Smaller peak 4 to the right of peak 3 is representative of other sterols. Peak
5 to the
left of peak 1 represents undesirable impurities. Although there is a degree
of uncertainty, it
is thought to be generated by dehydroxylated forms of sterols (campestane and
stigmastane).
In relation to the present invention, the most significant observation to be
made with
respect to the FTGURE is that peak S indicating the presence of impurities
does not appear in
the case of hydrogenation with ethyl acetate whereas it does appear in the
cases of
hydrogenation with either ethanol or isopropanol.
_g_

Representative Drawing

Sorry, the representative drawing for patent document number 2267929 was not found.

Administrative Status

2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.

Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee  and Payment History  should be consulted.

Event History

Description Date
Inactive: IPC from MCD 2006-03-12
Time Limit for Reversal Expired 2003-04-07
Application Not Reinstated by Deadline 2003-04-07
Deemed Abandoned - Failure to Respond to Maintenance Fee Notice 2002-04-08
Inactive: Delete abandonment 2001-05-16
Appointment of Agent Requirements Determined Compliant 2001-05-11
Inactive: Office letter 2001-05-11
Inactive: Office letter 2001-05-11
Revocation of Agent Requirements Determined Compliant 2001-05-11
Letter Sent 2001-04-30
Letter Sent 2001-04-30
Deemed Abandoned - Failure to Respond to Maintenance Fee Notice 2001-04-06
Appointment of Agent Request 2001-04-06
Revocation of Agent Request 2001-04-06
Inactive: Single transfer 2001-04-06
Application Published (Open to Public Inspection) 2000-10-06
Inactive: Cover page published 2000-10-05
Letter Sent 1999-08-23
Inactive: Single transfer 1999-07-27
Inactive: First IPC assigned 1999-05-27
Inactive: Courtesy letter - Evidence 1999-05-11
Inactive: Filing certificate - No RFE (English) 1999-05-10
Filing Requirements Determined Compliant 1999-05-10
Application Received - Regular National 1999-05-07

Abandonment History

Abandonment Date Reason Reinstatement Date
2002-04-08
2001-04-06

Maintenance Fee

The last payment was received on 2001-04-06

Note : If the full payment has not been received on or before the date indicated, a further fee may be required which may be one of the following

  • the reinstatement fee;
  • the late payment fee; or
  • additional fee to reverse deemed expiry.

Please refer to the CIPO Patent Fees web page to see all current fee amounts.

Fee History

Fee Type Anniversary Year Due Date Paid Date
Application fee - small 1999-04-06
Registration of a document 1999-07-27
MF (application, 2nd anniv.) - small 02 2001-04-06 2001-04-06
Registration of a document 2001-04-06
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
FORBES MEDI-TECH INC.
Past Owners on Record
ALFRED WONG
WILFRED NICHOLAS BOGUSKI
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Description 1999-04-06 8 327
Claims 1999-04-06 2 64
Abstract 1999-04-06 1 28
Drawings 1999-04-06 1 7
Cover Page 2000-10-03 1 32
Filing Certificate (English) 1999-05-10 1 165
Courtesy - Certificate of registration (related document(s)) 1999-08-23 1 140
Reminder of maintenance fee due 2000-12-07 1 112
Courtesy - Certificate of registration (related document(s)) 2001-04-30 1 113
Courtesy - Abandonment Letter (Maintenance Fee) 2002-05-06 1 183
Correspondence 1999-05-11 1 30
Correspondence 2001-04-06 2 68
Correspondence 2001-05-11 1 13
Correspondence 2001-05-11 1 15
Fees 2001-04-06 1 33